Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02047110
Brief Title: BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)

First Submitted : January 24, 2014
First Submitted that Met QC Criteria : January 24, 2014
First Posted : January 28, 2014 (Estimate)

Results First Submitted : May 3, 2019
Results First Submitted that Met QC Criteria : May 30, 2019
Results First Posted : May 31, 2019

Last Update Submitted that Met QC Criteria : May 30, 2019
Last Update Posted : May 31, 2019